Summanr A nested lung cancer case-control study was carried out using 397 12 h unrne samples originally collected from a cohort of over 26 000 women aged 40-64 at entry who were then followed for up to 15 years. The urine samples from active smokers were first identified using a simple qualitative method and their total nicotine metabolites creatinine ratios then determined by automated colorimetric methods. The results obtained demonstrated the capacity of nicotine metabolite estimations in a single 12 h sample of unrne to predict the subsequent risk of lung cancer. The risk of lung cancer among the biochemically proven active smokers during this period was 7.8 times that of the non-smokers, suggesting that the dose-response relationship between smoking and lung cancer is no less steep in women than in men. The smoking-related risk of adenocarcinoma was less than that of other lung carcinomas. It is suggested that this biochemical epidemiology approach to exploring the relationship between smoking and lung cancer could profitably be applied to the study of other smoking-related diseases.
The limitations to studying the dose dependence of lung cancer among active or passive smokers using self-reported daily cigarette consumptions or exposures to environmental tobacco smoke have been discussed in our companion paper (De Waard et al., 1995) . This paper then described the successful application of a direct biochemical epidemiological approach in which the risks of developing lung cancer among both active and passive smokers were shown to be highly correlated with the ratios of cotinine,/creatinine in single 12 h urine samples collected up to 15 years previously.
Previously the most widely used direct methods for assessing the relative inhalation of tobacco smoke by active smokers have been to determine the plasma, salivary or urinary concentrations of the nicotine metabolite cotinine using either gas-liquid chromatographic or radioimmunoassay methods (Hill et al.. 1983; Jarvis et al.. 1984; Russell et al., 1986; Armitage et al.. 1988; Wall et al.. 1988; Woodward et al.. 1991) . Simpler. cheaper and more rapid manual and automated colorimetnrc methods have also been reported to identify active smokers and to estimate their unrnary concentrations of nicotine together with cotinine and all their other pyridyl-containing metabolites (total nicotine metabolites. TNM) (Peach et al.. 1985; Barlow et al., 1987; Puhakainen et al., 1987; Withey et al.. 1992) .
Studies of cotinine blood levels (Benowitz et al., 1983) , comparisons of nicotine blood levels after intravenous dosage and ad libitum smoking (Benowitz and Jacob, 1984) and urinary TNM excretion (Peach et al., 1985) have all shown that individual smokers differ greatly in the efficiencies with which they smoke their cigarettes. Recently studies employing gas chromatography-mass spectrometry (GC-MS) techniques for specifically estimating all the major metabolites of nicotine have shown that the proportions of inhaled nicotine doses eliminated in the urine as cotinine by active smokers vary greatly between individuals (Byrd et al., 1992; Benowitz et al., 1994 (De Waard et al., 1995) .
Participants and methds
In 1974 a population-based screening programme was initiated for the early detection of breast cancer in a cohort of over 26 000 women aged 40-64 living in the city of Utrecht (the DOM project). From each participant a 12 h urine sample was collected which covered the night before attending screening and stored thereafter at -20°C.
In the framework of evaluating the DOM project we established a mortality register (all causes) with the cooperation of all the general practitioners in the city of Utrecht. It was also possible to make use of The Netherlands Cancer Registry. Linkage with this register was performed in such a way that legal requirements for privacy protection were met. This gave the opportunity to perform a nested case-control study.
During 15 years' follow-up 92 lung cancer cases were found in this cohort. For each case 2-4 controls were selected by computer, having about the same age and day of urine collection. Thus, the material for biochemical analysis consisted of urine samples from 92 lung cancer cases and 305 controls. A detailed description of the identification of the lung cancer cases, logistics of the collection and retrieval of the urine samples, and the GC-MS determination of their cotimine concentrations is given in the accompanying paper (De Waard et al.. 1995 The excellent results obtained using the simple qualitative diethylthiobarbituric acid extraction procedure to distinguish between active smokers on the one hand, and non-smokers and passive smokers on the other, confirms the original results obtained using the method (Peach et al., 1985) . It is noteworthy that the cut-off point for the qualitative test occurred at concomitant cotinine concentrations of about lOOIpg 1-', a level similar to the optimal cut-off point (about 70 pg 1-1) based on self-reported smoking status and urinary cotinine concentrations (De Waard et al., 1995) . These cutoff points are also similar to that (50 pg 1-') recom ed by Jarvis et al. (1987) and a value of about 128pg 1-' suggted by the results obtained by Wald et al. (1984) . Tbese findings therefore indicate that the simple, cheap diethylthiobarbituric acid extraction procedure, which has a potential throughput of greater than 60 samples per hour, is at kast as efficient at identifying active smokers as the much more technicilly demanding cotinine-based procedures.
The results presented in Tables I and H show that the slightly higher odds ratio for the risk of lung cancer in biochemically proven smokers (7.8) as compared with a value of 6.3 for self-admitted smokers arose through the presence of a significnt proportion (9%) of very light smokers. Since their nicotine intakes were siilar to those of more heavily exposed passive smokers (De Waard et al., 1995) it is suggested that they were probably non-addicted social smokers. By contrast with numerous other studies reported in the literature it is noteworthy that the women followed in our study were remarkably truthful in reporting their smoking status. Thus not a single active smoker was identified among the self-reported non-smokers. Such 'deceivers' (Jarvis et al., 1987) can considerably complicate the interpretation of questionnaire-based epidemiological investigations and provide an important incentive for using the direct biochemical epidemiology approach. The absence of deceivers in our study may well be due to the fact that when the smoling histories were obtained (1975-83) there was much less public awareness of the health dangers of smoking.
Another reason that TNM/creatinine ratios should provide a much better esfimate of smoke intake and therfore a steeper dose-response curve for lung cancer risk than selfreported cigarette consumption is the previously described evidence for the greatly differing efficiencies with which individuals smoke their cigarettes. To test whether this might have been the case, the biochemically proven active smokers were divided according to their TNM/creatinine ratios into unequal tertils so as to match the proportions of smokers in the three self-reporting categories set out in Table I . However a chi-squared analysis showed that the dose-dependent risk relationship based on TNM/creatnine ratios [odds ratios of 1.1 (0.3-3.9), 8.6 (4.2-17.8) and 29.5 (11.3-77 .2) respectively], was not significantly steeper (P = 0.1 1) than that based on cigarette consumptions [1.3 (0.4-4. 2), 9.7 (4.9-19.5) and 9.4 (3.9-22.5) respectively].
A comparison of the odds ratios for lung cancer risk among equal tertiles of active smokers based on TNM/ creatinine ratios set out in Table II (0.9, 14.1 and 18.8 respectively) with the corresponding odds ratios (1.3, 10.3 and 9.8 respectively) based on cotinine/creatinine ratios (De Waard et al., 1995) shows that the simpler colorimetric method for estimating total nicotine metabolites performed at least as weil in demonstrating the dose dependence of smoking-related lung cancer risk as the highly sophisticated GC-MS method for estmating cotinine. The eviden obtained in our study demonstrating the large individual differences in the proportions of inhaled nicotine excreted as cotinine confirms the findings of Byrd et al. (1992) and Benowitz et al. (1994) .
At first sight it might seem surprising that single estimates of urinary nicotine metabolite excretion were so predictive of subsequent lung cancer risk. However there is a considerable body of indit evidence to suggest that once the smoking habit is firmly established daily individual nicotine intakes are likely to continue for many years with little change. Thus numerous studies have shown that when individuals change to smoking brands of cigarettes with reduced nicotine yields they rapidly alter their mode of smoking (compensate) so as to obtain their former accustomed daily nicotine intakes (for references see Withey et al., 1992) . The fact that urinary TNM/creatinine ratios of samples obtained when the cohort was enrolled into the study correlated well with those obtained a year later provides objective evidence for the assumption that these reflected the chronic smoking habits of the women in the cohort. Furthermore, the fact that the tar-nicotine ratios of most brands of cigarettes are very similar (Phillips and Waller, 1991) , implies that intakes of carcinogenic tar will be closely related to those of nicotine.
The overall odds ratio of 7.8 for biochemically proven smokers (Table H) confirms the cotinine-based evidence presented in our companion paper (De Waard et al., 1995) and supports the conclusion of Garfinkel and Stellman (1988) that after allowing for the duration of smoking, women A 7q probably have a lung cancer risk of similar magnitude to that encountered by men.
The results presented in Table III confirm the cotimnnebased findings reported and discussed in our companion paper (De Waard et al., 1995) that the relationship between smoking and adenocarcinoma of the lung is much weaker than that of other histological types.
The biochemical epidemiology approach used in this investigation to explore the relationship between smoking and lung cancer could profitably be employed in the study of other smoking-related conditions such as ischaemic heart disease, and also to overall mortality in situations where appropriate urine banks are available. The great advantage of this approach is that it does not require either histories of active smoking or evidence concerning potential exposure to environmental tobacco smoke.
Unrne samples can be rapidly tested by the qualitative diethylthiobarbitunic acid extraction procedure (Peach et al., 1985) and the dose dependence of disease in the active smokers explored by determiining the TNM creatinine ratios by the automated colorimetric method of Puhakainen et al. (1987) . The possible influence of passive smoking can then be assessed using cotinine-based assays (Wald et al.. 1984 : De Waard et al.. 1995 .
